Zhuang Jin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhuang Jin has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Fang Xie
Department of Child Health Care, Huangshi Maternity and Child Health Care Hospital, Wuhan, China
2 shared publications - Huarui Du
Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China
2 shared publications - Jue Zhang
Academy for Advanced Interdisciplinary Studies, Peking University
2 shared publications - Mingbo Zhang
Henan University (China)
2 shared publications - Shijie Zhang
Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China
2 shared publications - Xiaoqi Tian
Ultrasonography Department, the General Hospital of the People’s Liberation Army, Beijing, China
2 shared publications
Latest Publications
- 1 March 2022
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 41 (11) , 2789-2802
Targeting Diagnosis of High‐Risk Papillary Thyroid Carcinoma Using Ultrasound Contrast Agent With the BRAFV600E Mutation
Objective High-risk papillary thyroid carcinoma (PTC) patients with BRAF mutation have lymph node and distant metastasis and poor prognosis. Therefore, this study aims to develop a targeted ultrasound contrast agent for the BRAF(V600E) mutation to screen high-risk PTC at early stage. Methods The targeted lipid nanobubbles carrying BRAF(V600E) antibody were prepared using thin film hydration-sonication and avidin-biotin binding methods. The physicochemical properties and stability of the targeted nanobubbles were detected by transmission electron microscopy, atomic force microscopy, and confocal laser scanning microscopy. The target binding abilities of the targeted nanobubbles in the PTC cells (B-CPAP) overexpressed mutant BRAF(V600E) were evaluated by immunofluorescence staining, quantitative real-time polymerase chain reaction, western blot, and fluorescence microscopy. After PTC tumor models overexpressed mutant BRAF(V600E) were established, the enhanced images of targeted lipid nanobubbles and untargeted lipid nanobubbles on PTC tumors in nude mice were observed using contrast-enhanced ultrasound imaging. Results The targeted lipid nanobubbles revealed uniform, round morphology, and good stability with a nanoscale size. Besides, BRAF(V600E) monoclonal antibody was observed to be combined on the surface of lipid nanobubbles. Furthermore, the targeted nanobubbles had a good targeting diagnosis ability in PTC cells with BRAF(V600E) overexpression. Moreover, the targeted nanobubbles had better ultrasound enhancement and peak intensity of the time-intensity curve (P < .001) in PTC tumors with BRAF(V600E) overexpression as compared to the untargeted lipid nanobubbles. Conclusion The targeted lipid nanobubbles carrying BRAF(V600E) antibody could be regarded as a potential targeted ultrasound contrast agent for the diagnosis of high-risk PTC.
- 1 March 2022
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 41 (11) , 2789-2802
Targeting Diagnosis of High‐Risk Papillary Thyroid Carcinoma Using Ultrasound Contrast Agent With the BRAFV600E Mutation
Objective High-risk papillary thyroid carcinoma (PTC) patients with BRAF mutation have lymph node and distant metastasis and poor prognosis. Therefore, this study aims to develop a targeted ultrasound contrast agent for the BRAF(V600E) mutation to screen high-risk PTC at early stage. Methods The targeted lipid nanobubbles carrying BRAF(V600E) antibody were prepared using thin film hydration-sonication and avidin-biotin binding methods. The physicochemical properties and stability of the targeted nanobubbles were detected by transmission electron microscopy, atomic force microscopy, and confocal laser scanning microscopy. The target binding abilities of the targeted nanobubbles in the PTC cells (B-CPAP) overexpressed mutant BRAF(V600E) were evaluated by immunofluorescence staining, quantitative real-time polymerase chain reaction, western blot, and fluorescence microscopy. After PTC tumor models overexpressed mutant BRAF(V600E) were established, the enhanced images of targeted lipid nanobubbles and untargeted lipid nanobubbles on PTC tumors in nude mice were observed using contrast-enhanced ultrasound imaging. Results The targeted lipid nanobubbles revealed uniform, round morphology, and good stability with a nanoscale size. Besides, BRAF(V600E) monoclonal antibody was observed to be combined on the surface of lipid nanobubbles. Furthermore, the targeted nanobubbles had a good targeting diagnosis ability in PTC cells with BRAF(V600E) overexpression. Moreover, the targeted nanobubbles had better ultrasound enhancement and peak intensity of the time-intensity curve (P < .001) in PTC tumors with BRAF(V600E) overexpression as compared to the untargeted lipid nanobubbles. Conclusion The targeted lipid nanobubbles carrying BRAF(V600E) antibody could be regarded as a potential targeted ultrasound contrast agent for the diagnosis of high-risk PTC.
- Open Access
- 27 February 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 8, 53223-53231
A Novel Interpretable Computer-Aided Diagnosis System of Thyroid Nodules on Ultrasound Based on Clinical Experience
Computer-aided diagnosis systems (CADs) present valuable second opinions to radiologists in diagnosis. Many studies on thyroid nodules have proposed various CADs to provide a binary result, benignity or malignancy, for doctors, ignoring interpretability of more ultrasonic features that could be more useful. We develop an interpretable CADs (iCADS) that utilizes deep-learning networks’ classification power and interpretability potential of clinical guidelines, like TIRADS, a well-established scale for thyroid nodules. iCADS incorporates a main neural-networks model and six neural-network based interpreters. The outputs of the six interpreters are compared with TIRADS guidelines and the matched result will form a report, more than a benignity or malignancy result, for radiologists. Clinical images of 16,946 thyroid nodules from 5,885 patients were used to train the proposed iCADS. An extra experimental data set containing 501 images were used to test the performance of the model. For better illustrating the assistant ability of iCADS, we also recruited ten junior radiologists to make diagnosis decisions with or without the help of different versions of iCADS. The experiments demonstrated that iCADS can largely improve junior radiologists diagnosis with the help of interpreter strategy. These experiments are also the very first attempt to evaluate the effect of interpretability of deep-learning based CADs in clinical practice. Comparison experiments with other deep-learning based CADs and traditional CADs indicated that the interpreter strategy can easily be combined to other intelligent CADs without the loss of performance. The framework of iCADS can also inspire more research on the development of CADs.
- 27 February 2020
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Access
- Vol. 8, 53223-53231
Open AccessA Novel Interpretable Computer-Aided Diagnosis System of Thyroid Nodules on Ultrasound Based on Clinical Experience
Computer-aided diagnosis systems (CADs) present valuable second opinions to radiologists in diagnosis. Many studies on thyroid nodules have proposed various CADs to provide a binary result, benignity or malignancy, for doctors, ignoring interpretability of more ultrasonic features that could be more useful. We develop an interpretable CADs (iCADS) that utilizes deep-learning networks’ classification power and interpretability potential of clinical guidelines, like TIRADS, a well-established scale for thyroid nodules. iCADS incorporates a main neural-networks model and six neural-network based interpreters. The outputs of the six interpreters are compared with TIRADS guidelines and the matched result will form a report, more than a benignity or malignancy result, for radiologists. Clinical images of 16,946 thyroid nodules from 5,885 patients were used to train the proposed iCADS. An extra experimental data set containing 501 images were used to test the performance of the model. For better illustrating the assistant ability of iCADS, we also recruited ten junior radiologists to make diagnosis decisions with or without the help of different versions of iCADS. The experiments demonstrated that iCADS can largely improve junior radiologists diagnosis with the help of interpreter strategy. These experiments are also the very first attempt to evaluate the effect of interpretability of deep-learning based CADs in clinical practice. Comparison experiments with other deep-learning based CADs and traditional CADs indicated that the interpreter strategy can easily be combined to other intelligent CADs without the loss of performance. The framework of iCADS can also inspire more research on the development of CADs.
- 1 October 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 2334-2336
Integrating Clinical Knowledge in a Thyroid Nodule Classification Model Based on
Deep neural network models are currently facing problems due the weak interpretability of predicted results. One solution would involve integrating the clinical knowledge and classifiers. In this study, we utilized mature clinical experiences from TI-RADS, and also trained a multi-label cost-sensitive classification network. The results show that the end-to-end classification model based on cost-sensitive loss function is a more effective way to integrate clinical knowledge into the deep neural network.
- 1 October 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 2334-2336
Integrating Clinical Knowledge in a Thyroid Nodule Classification Model Based on
Deep neural network models are currently facing problems due the weak interpretability of predicted results. One solution would involve integrating the clinical knowledge and classifiers. In this study, we utilized mature clinical experiences from TI-RADS, and also trained a multi-label cost-sensitive classification network. The results show that the end-to-end classification model based on cost-sensitive loss function is a more effective way to integrate clinical knowledge into the deep neural network.
- 1 August 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 187-190
Design and Implementation of WA Face Recognition System based on Small WeChat Program
Aiming at the disadvantages of traditional check-in time occupation and complicated personnel operation, this paper develops a system for WA face recognition with the help of small WeChat program. Based on the features of Wa people's faces, the system designs three modules: user authentication, face uploading and face recognition. Realizing it by small WeChat program development tools and Django framework, the background uses MySQL database as the base database. In order to achieve better recognition, the 1000 WA face pictures collected are mainly constructed, the data set is trained by convolution neural network, the ratio of training set to test set is 8:2, and the result of final test reaches 98%.
- 1 August 2019
- Published by Institute of Electrical and Electronics Engineers (IEEE)
- p. 187-190
Design and Implementation of WA Face Recognition System based on Small WeChat Program
Aiming at the disadvantages of traditional check-in time occupation and complicated personnel operation, this paper develops a system for WA face recognition with the help of small WeChat program. Based on the features of Wa people's faces, the system designs three modules: user authentication, face uploading and face recognition. Realizing it by small WeChat program development tools and Django framework, the background uses MySQL database as the base database. In order to achieve better recognition, the 1000 WA face pictures collected are mainly constructed, the data set is trained by convolution neural network, the ratio of training set to test set is 8:2, and the result of final test reaches 98%.
- 19 February 2013
- Published by Wiley in ChemInform
- Vol. 44 (8)
ChemInform Abstract: Replacement of BF4‐ by PF6‐ Makes Selectfluor Greener.
Changing the counterion in Selectfluor® from tetrafluoroborate to hexafluorophosphate significantly reduces catalyst loading in amide oxidation reactions.
- 19 February 2013
- Published by Wiley in ChemInform
- Vol. 44 (8)
ChemInform Abstract: Replacement of BF4‐ by PF6‐ Makes Selectfluor Greener.
Changing the counterion in Selectfluor® from tetrafluoroborate to hexafluorophosphate significantly reduces catalyst loading in amide oxidation reactions.